Phytobezoar Associated with Levodopa-carbidopa Intestinal Gel Infusion in Patients with Parkinson's Disease: A Case Report and Literature Review

被引:2
|
作者
Ueno, Tatsuya [1 ]
Hanabata, Norihiro [2 ]
Katagai, Atsuko [1 ]
Okudera, Rena [1 ,3 ]
Arai, Akira [1 ]
Tomiyama, Masahiko [4 ]
机构
[1] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan
[2] Aomori Prefectural Cent Hosp, Dept Gastroenterol, Aomori, Japan
[3] Natl Def Med Coll, Dept Internal Med, Div Neurol, Tokorozawa, Saitama, Japan
[4] Hirosaki Univ, Dept Neurol, Grad Sch Med, Hirosaki, Aomori, Japan
关键词
levodopa-carbidopa intestinal gel; parkinson's disease; phytobezoar; device-aided therapy; J-tube; gastrointestinal symptom; COMPLICATION;
D O I
10.2169/internalmedicine.7210-21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel (LCIG) is an established device-aided therapy for advanced Parkinson's disease (PD). Phytobezoar associated with LCIG is a rare device-related complication and presents with exacerbations of gastrointestinal and PD symptoms. We herein report the case of a phytobezoar that was formed at a knot on the pigtail-shaped J-tube and developed only in association with postprandial abdominal pain, similar to a feeling of a tube being pulled in without an exacerbation of PD symptoms. Such abdominal pain may be a warning sign of phytobezoar in LCIG-treated patients. Despite device-related complications, high-pressure alarms are not always present, and PD symptoms are not always exacerbated.
引用
收藏
页码:3317 / 3320
页数:4
相关论文
共 50 条
  • [41] Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease
    Fernandez H.H.
    Robieson W.Z.
    Chatamra K.
    Dubow J.
    Eaton S.
    Benesh J.A.
    Odin P.
    npj Parkinson's Disease, 2 (1)
  • [42] Weight loss and decubitus duodenal ulcer in Parkinson's disease treated with levodopa-carbidopa intestinal gel infusion
    Martino, Tommaso
    Melchionda, Donato
    Tonti, Paolo
    De Francesco, Vincenzo
    Lalla, Alessandra
    Specchio, Luigi Maria
    Avolio, Carlo
    JOURNAL OF NEURAL TRANSMISSION, 2016, 123 (12) : 1395 - 1398
  • [43] Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease: A Systematic Review
    Karin Wirdefeldt
    Per Odin
    Dag Nyholm
    CNS Drugs, 2016, 30 : 381 - 404
  • [44] Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
    Moes, Harmen R.
    Buskens, Erik
    van Laar, Teus
    LANCET NEUROLOGY, 2024, 23 (09): : 856 - 857
  • [45] ADVERSE EVENTS AND QUALITY OF LIFE IN ADVANCED PARKINSON'S DISEASE PATIENTS TREATED WITH LEVODOPA-CARBIDOPA INTESTINAL GEL INFUSION THERAPY
    Premzl, M.
    Kriznar, N. Zupancic
    Kramberger, M. Gregoric
    Kojovic, M.
    Ocepek, L.
    Rajnar, R.
    Plut, S.
    Pirtosek, Z.
    Trost, M.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E66 - E66
  • [46] Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion
    Solla, Paolo
    Fasano, Alfonso
    Cannas, Antonino
    Mulas, Cesare Salvatore
    Marrosu, Maria Giovanna
    Lang, Anthony E.
    Marrosu, Francesco
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (08) : 968 - 971
  • [47] Levodopa-Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial
    Freire-Alvarez, Eric
    Kurca, Egon
    Lopez Manzanares, Lydia
    Pekkonen, Eero
    Spanaki, Cleanthe
    Vanni, Paola
    Liu, Yang
    Sanchez-Solino, Olga
    Barbato, Luigi M.
    MOVEMENT DISORDERS, 2021, 36 (11) : 2615 - 2623
  • [48] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson's disease
    Valldeoriola, Francesc
    Jose Catalan, Maria
    Escamilla-Sevilla, Francisco
    Freire, Eric
    Olivares, Jesus
    Cubo, Esther
    Santos Garcia, Diego
    Calopa, Matilde
    Martinez-Martin, Pablo
    Carlos Parra, Juan
    Arroyo, Gloria
    Matias Arbelo, Jose
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [49] Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Udd, Marianne
    Lyytinen, Jukka
    Eerola-Rautio, Johanna
    Kenttamies, Anu
    Lindstrom, Outi
    Kylanpaa, Leena
    Pekkonen, Eero
    BRAIN AND BEHAVIOR, 2017, 7 (07):
  • [50] Direct Endoscopic Jejunostomy for the Administration of Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
    Vinh-an Phan
    Schoeman, Mark
    Kimber, Thomas
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB307 - AB308